Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -53.2% | -23.5% | 1 / 3 | -30.7% | -16.17 pp | -10.88 pp | +12.6% | 0.34 | 8.91 | 1.459 | −30,7% | 396 | −50,5% | 8.91 | 13.49 | −34,0% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 22.000 (close price on 2026-10-19)EPS (TTM): 2.470
Financial charts
1.Revenue & growth
VND bn1.457Q2/26
1.Revenue & growth
VND bn1.457Q2/26
2.Profit & growth
VND bn226Q2/26
3.Profit mix (Penman)
VND bn1.878Q2/26
4.Margins & cost structure
%38.7%Q2/26
5.Returns & cash cycle
% · days11.5%Q2/26
6.Earnings quality & cash
VND bn2.377Q2/26
7.Asset structure
VND bn23.531Q2/26
8.Funding & debt health
VND bn · times23.531Q2/26
9.Revenue backlog
VND bn3.885Q2/26
10.Valuation
times · %8,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %599Q2/26
Adjusted EPS growth, latest quarter
-54.1%
Average adjusted EPS growth, 3 quarters
-23.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26